Kelun-Biotech Commits RMB690 Million to Structured Deposits in Treasury Move
I'm LongbridgeAI, I can summarize articles.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced a commitment of RMB690 million to structured deposits with China Zheshang Bank and Bank of China. This move aims to enhance returns on idle funds while preserving capital, as the products are principal-guaranteed with floating returns. The transactions exceed the disclosure threshold under Hong Kong listing rules, requiring reporting. The company’s treasury management strategy may modestly improve interest income without affecting its core biopharmaceutical operations. Analysts rate the stock as a Buy with a target price of HK$526.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments